c98c502b0766e21ece355680777004b27bf3bc29
CREBBP.md
| ... | ... | @@ -13,7 +13,7 @@ This gene has some recurrent sites of mutations (hotspots), mostly in the HAT do |
| 13 | 13 | ## Experimental Evidence |
| 14 | 14 | CREBBP missense mutations often affect the histone acetyltransferase (HAT) domain, crucial for regulating gene expression through chromatin modification, or generate a truncated protein.[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
| 15 | 15 | In a transgenic mouse model, CREBBP loss cooperated with BCL2 overexpression to promote B-cell lymphomagenesis.[@garcia-ramirezCrebbpLossCooperates2017] |
| 16 | -Mutations in CREBBP and EP300 affect a common pathway and have been described as mutually exclusive due to some functional redundancy.[@pasqualucciInactivatingMutationsAcetyltransferase2011a; @veazeyCARM1InhibitionReduces2020b] Studies using genome-wide CRISPR-Cas9 screens have identified synthetic lethal interactions between CREBBP and EP300, suggesting that targeting one may affect the viability of cells with mutations in the other.[@nieGenomewideCRISPRScreens2021] |
|
| 16 | +Mutations in CREBBP and EP300 affect a common pathway and have been described as mutually exclusive due to some functional redundancy.[@pasqualucciInactivatingMutationsAcetyltransferase2011a; @veazeyCARM1InhibitionReduces2020] Studies using genome-wide CRISPR-Cas9 screens have identified synthetic lethal interactions between CREBBP and EP300, suggesting that targeting one may affect the viability of cells with mutations in the other.[@nieGenomewideCRISPRScreens2021] |
|
| 17 | 17 | |
| 18 | 18 | ## History |
| 19 | 19 | |
| ... | ... | @@ -32,9 +32,9 @@ timeline |
| 32 | 32 | |Entity|Tier|Description | |
| 33 | 33 | |:------:|:----:|--------------------------------------| |
| 34 | 34 | ||2|relevance in MZL not firmly established[@parryWholeExomeSequencing2013] | |
| 35 | -||1|high-confidence PMBL/cHL/GZL gene[@dunsCharacterizationDLBCLPMBL2021b] | |
|
| 36 | -| |1-EE |high-confidence DLBCL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011a] | |
|
| 37 | -| |1-EE |high-confidence FL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011a] | |
|
| 35 | +||1|high-confidence PMBL/cHL/GZL gene[@dunsCharacterizationDLBCLPMBL2021] | |
|
| 36 | +| |1-EE |high-confidence DLBCL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] | |
|
| 37 | +| |1-EE |high-confidence FL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] | |
|
| 38 | 38 | | |2 |association with BL is tenuous[@loveGeneticLandscapeMutations2012]| |
| 39 | 39 | |
| 40 | 40 | ## Mutation incidence in large patient cohorts (GAMBL reanalysis) |